Tenax Therapeutics Inc (TENX)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | DOOGAN, DECLAN | Director | Common Stock | Acquisition | 53,000 | 1.92 |
| Sep 15, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 4,850 | 1.822 |
| Sep 11, 2026 | STAAB, THOMAS R II | Chief Financial Officer | Common Stock | Acquisition | 5,675 | 1.935 |
| Sep 11, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 6,000 | 1.875 |
| Sep 3, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 900,000 | 1.782 |
| Sep 2, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 187,704 | 1.799 |
| Sep 1, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 179,058 | 1.796 |
| Aug 31, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 403,571 | 1.791 |
| Aug 24, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 107,374 | 1.754 |
| Aug 21, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 716,369 | 1.768 |
| Aug 20, 2026 | ADAR1, CAPITAL MANAGEMENT, LLC | 10% Owner | Common Stock | Acquisition | 202,124 | 1.779 |
| Jul 13, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Stock Option (right to buy) | Disposal | 219 | 0 |
| Jul 13, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Stock Option (right to buy) | Disposal | 8,500 | 0 |
| Jul 13, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 219 | 3.549 |
| Jul 13, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 8,500 | 5.94 |
| May 11, 2026 | STAAB, THOMAS R II | Chief Financial Officer | Common Stock | Acquisition | 10,000 | 0 |
| May 11, 2026 | STAAB, THOMAS R II | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 450,000 | 0 |
| Jan 30, 2026 | MCGAULEY, THOMAS | Interim CFO | Stock Option (right to buy) | Acquisition | 50,000 | 0 |
| Jan 9, 2026 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Stock Option (right to buy) | Acquisition | 450,000 | 0 |
| Jan 9, 2026 | PROEHL, GERALD T | Director | Stock Option (right to buy) | Acquisition | 3,000 | 0 |
| Jan 9, 2026 | DAVIDSON, MICHAEL H. | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jan 9, 2026 | DOOGAN, DECLAN | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jan 9, 2026 | ALMENOFF, JUNE SHERIE | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Jan 9, 2026 | RICH, STUART | Director, Chief Medical Officer | Stock Option (right to buy) | Acquisition | 250,000 | 0 |
| Jan 9, 2026 | HUNTER, ROBYN | Director | Stock Option (right to buy) | Acquisition | 30,000 | 0 |
| Dec 9, 2025 | RICH, STUART | Director, Chief Medical Officer | Common Stock | Acquisition | 2,500 | 10.217 |
| Dec 8, 2025 | RICH, STUART | Director, Chief Medical Officer | Common Stock | Acquisition | 2,500 | 10.1 |
| Dec 4, 2025 | RICH, STUART | Director, Chief Medical Officer | Common Stock | Acquisition | 2,500 | 9.199 |
| Dec 3, 2025 | RICH, STUART | Director, Chief Medical Officer | Common Stock | Acquisition | 1,500 | 9.079 |
| Dec 2, 2025 | RICH, STUART | Director, Chief Medical Officer | Common Stock | Acquisition | 1,000 | 9.006 |
| Nov 20, 2025 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 538 | 7.589 |
| Nov 19, 2025 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 455 | 7.509 |
| Nov 18, 2025 | ALMENOFF, JUNE SHERIE | Director | Common Stock | Acquisition | 1,900 | 7.516 |
| Nov 18, 2025 | GIORDANO, CHRISTOPHER THOMAS | Director, CEO | Common Stock | Acquisition | 1,612 | 7.755 |
| Nov 17, 2025 | ALMENOFF, JUNE SHERIE | Director | Common Stock | Acquisition | 93 | 7.15 |
| Nov 17, 2025 | MCGAULEY, THOMAS | Interim CFO | Common Stock | Acquisition | 5,000 | 7.228 |
| Nov 17, 2025 | MCGAULEY, THOMAS | Interim CFO | Common Stock | Acquisition | 1,000 | 7.35 |
| Nov 17, 2025 | MCGAULEY, THOMAS | Interim CFO | Common Stock | Acquisition | 2,000 | 7.337 |